Active Pharmaceutical Ingredients (API) Market in Asia-Pacific to 2016 - The Merchant Market for Generics Continues to Grow as the Competition Increases

NEW YORK, July 11, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Active Pharmaceutical Ingredients (API) Market in Asia-Pacific to 2016 - The Merchant Market for Generics Continues to Grow as the Competition Increases

http://www.reportlinker.com/p0569998/Active-Pharmaceutical-Ingredients-API-Market-in-Asia-Pacific-to-2016---The-Merchant-Market-for-Generics-Continues-to-Grow-as-the-Competition-Increases.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Generic_Drug

Active Pharmaceutical Ingredients (API) Market in Asia-Pacific to 2016 - The Merchant Market for Generics Continues to Grow as the Competition Increases

Summary

GBI Research's report, "Active Pharmaceutical Ingredients (API) Market in Asia-Pacific to 2016 - The Merchant Market for Generics Continues to Grow as the Competition Increases" provides detailed insight into the Asia-Pacific API market. The research presents detailed analysis and forecasts of the major economic and market trends affecting the API markets in this region. The report contains market forecasts, product type analysis, drivers and restraints, and competitive landscape of major producers in the region. In addition, it includes market forecasts, product type analysis, therapeutic categories analysis and SWOT analysis of the API markets in the major countries of the region. Overall, the report presents a comprehensive analysis of the Asia-Pacific API market, covering all the major parameters. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

Asia-Pacific is the third largest regional market for APIs by revenue in the world after North America and Europe. The region is the fastest growing API market in the world. The Asia-Pacific API market grew consistently at a CAGR of 6.7% from 2005 to 2010. The year-on-year growth rate also increased continuously in this period. It is expected to witness an even higher growth rate in the forecast period. The Asia-Pacific API market revenues will grow at a CAGR of 9.6% from 2010 to 2016.

Scope

- Market revenue data for APIs from 2005 to 2010 and forecast for six years to 2016.

- API markets in key countries in the region: Japan, China, India and Sourh Korea.

- API industry structure and market trends such as a shift in manufacturing and growth in biotechnology for the Asia-Pacific region.

- Drivers of the API market, such as the growth of generic drugs, and restraints, such as patent expiries and SWOT analysis of the API market for the region's key countries.

- Information on the competitive landscape, with shares of leading companies such as Pfizer Inc, AstraZeneca International, GlaxoSmithKline Pharmaceuticals, Sanofi-Aventis and Novartis.

- Analysis of API revenue based on product types in the Asia-Pacific market and in key countries of the region.

- Analysis of API revenue based on therapeutic categories in the key countries.

Reasons to buy

- Develop business strategies with the help of specific insights on the Asia-Pacific API market.

- Identify opportunities and challenges in the Asia-Pacific API market.

- Invest in the growing segments of the API market.

- Increase future revenue and profitability with the help of insights on the future opportunities and critical success factors in the Asia-Pacific API market.

- Benchmark your operations and strategies against the major players in the global API market.

1 Table of Contents

1 Table of Contents 3

1.1 List of Tables 6

1.2 List of Figures 7

2 Introduction 8

2.1 GBI Report Coverage 8

3 Asia-Pacific API Market 9

3.1 Asia-Pacific API Industry Structure 9

3.2 Asia-Pacific API Distribution Structure 10

3.3 Asia-Pacific API Industry Challenges 10

3.3.1 Growing Capacity May Prove out to be Surplus and become a Challenge to the Producers 10

3.3.2 Price Fluctuations Affect the Revenue Growth of the Asia-Pacific API market 10

3.3.3 Rising Raw Material Costs in India and China Threaten the Profit Margins of API Producers 10

3.4 Asia-Pacific API Market Overview 11

3.5 Asia-Pacific API Market Trends 12

3.5.1 API Manufacturing is Shifting from Western Countries to China and India 12

3.5.2 Indian Companies are Exporting to Japanese Market to Beat the Price Erosion in the US 12

3.5.3 Japanese Generic Market is Attracting Tie-Ups by Global Companies 12

3.5.4 The Focus on Biotech API Drugs in Asia-Pacific is Increasing 12

3.5.5 Some Companies in India are Making a Move Towards HPAPIs 12

3.5.6 Peptide APIs are Offering Growth Opportunities for the Region's Market 13

3.5.7 Indian Producers are Becoming Keen on Expansion Through Acquisitions 13

3.6 Asia-Pacific API Market Revenue Analysis and Forecasts to 2015 13

3.7 Asia-Pacific API Market Revenue Share Analysis by Product Type and Forecasts to 2016 15

3.7.1 Asia-Pacific API Market Revenue Share Analysis by Product Type Based on Synthesis Route and Forecast to 2016 16

3.7.2 Asia-Pacific API Market Revenue Share Analysis by Product Type Based on Customer Base and Forecast to 2016 19

3.8 Asia-Pacific API Market Revenue Share Analysis by Country and Forecasts to 2016 22

3.9 Asia-Pacific API Market Competitive Landscape 23

3.10 Force Field Analysis on Transition Toward Biotech API 24

3.10.1 Push Forces 25

3.10.2 Pull Forces 26

3.10.3 Conclusion 26

4 Japan API Market 27

4.1 Japan API Market Overview 27

4.2 Japan API Market Drivers 28

4.2.1 Increased Focus on Generic Sector Drugs will Help the Growth of the Overall API Market in Japan 28

4.2.2 Government Support for Generic Drugs Boosts the Country's API Market 28

4.2.3 Growth in the Ageing Population Drives the Growth of the API Market in Japan 28

4.3 Japan API Market Restraints 28

4.3.1 Mature Pharmaceutical Market Allows Less Scope for Growth to the API Market in the Country 28

4.3.2 Lesser Focus on Innovative Drugs to Reduce Healthcare Expenses May Hamper the Growth of the Japanese API market 28

4.4 Japan API Market Revenue Analysis and Forecasts to 2015 29

4.5 Japan API Market Revenue Share Analysis by Product Type and Forecasts to 2015 31

4.5.1 Japan API Market Revenue Share Analysis by Product Type Based on Synthesis Route and Forecasts to 2015 31

4.5.2 Japan API Market Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2015 34

4.6 Japan API Market Revenue Share Analysis by Therapeutic Category 37

4.7 Japan API Market SWOT Analysis 39

4.7.1 Strengths 39

4.7.2 Weaknesses 40

4.7.3 Opportunities 40

4.7.4 Threats 41

5 China API Market 42

5.1 China API Market Overview 42

5.2 China API Market Drivers 43

5.2.1 Rapidly Growing Economy Supports the Growth of the API Market 43

5.2.2 Growth in the Generics Drug Sector Spurs the Growth in Demand for APIs 43

5.2.3 Government's Plan to Develop Multi-level Insurance System Set to Boost the Growth of the API Market in China 43

5.2.4 Development in Biotech Drugs Improves the Growth of Biotech APIs 43

5.3 China API Market Restraints 43

5.3.1 Price Erosion Reduces the Revenue Growth of the API Market in China 43

5.3.2 The Global Economic Downturn in the Last Few Years has Impacted the Demand in the Chinese API Market 43

5.4 China API Market Revenue Analysis and Forecasts to 2015 44

5.5 China API Market Revenue Share Analysis by Product Type and Forecasts to 2015 46

5.5.1 China API Market Revenue Share Analysis by Product Type Based on Synthesis Route and Forecasts to 2015 46

5.5.2 China API Market Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2015 49

5.6 China API Market Revenue Share Analysis by Therapeutic Category 52

5.7 China API Import and Export Analysis 54

5.8 China API Market SWOT Analysis 58

5.8.1 Strengths 58

5.8.2 Weaknesses 59

5.8.3 Opportunities 59

5.8.4 Threats 59

6 India API Market 60

6.1 India API Market Overview 60

6.2 India API Market Drivers 60

6.2.1 Population Growth and Change in Demographics Set to Boost the Growth of API Market 60

6.2.2 Increasing Demand in Rural Areas and Tier II Cities Boost the Growth of API Market in India 60

6.2.3 Increasing Spending Capacity on Healthcare Facilities 61

6.3 India API Market Restraints 61

6.3.1 Price Erosion Leads to Reduced Growth in the Overall API Market 61

6.3.2 Economic Recession Leads to Reduced Consumption of API 61

6.4 India API Market Revenue Analysis and Forecasts to 2015 61

6.5 India API Market Revenue Share Analysis by Product Type and Forecasts to 2015 63

6.5.1 India API Market Revenue Share Analysis by Product Type Based on Synthesis Route and Forecasts to 2015 63

6.5.2 India API Market Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2015 66

6.6 India API Market Revenue Share Analysis by Therapeutic Category 69

6.7 India API Market SWOT Analysis 71

6.7.1 Strengths 71

6.7.2 Weaknesses 72

6.7.3 Opportunities 72

6.7.4 Threats 72

7 South Korea API Market 73

7.1 South Korea API Market Overview 73

7.2 South Korea API Market Drivers 73

7.2.1 Continued Growth in Generics Will Help the API Market Growth in South Korea 73

7.2.2 Increasing Focus on the Innovator Sector Will Drive the API Market 73

7.2.3 Support from the Government Will Help Growth in Innovator and Biotech Sector 73

7.3 South Korea API Market Restraints 73

7.3.1 Delay in Drug Development Process 73

7.4 South Korea API Market Revenue Analysis and Forecasts to 2015 74

7.5 South Korea API Market Revenue Share Analysis by Product Type and Forecasts to 2015 76

7.5.1 South Korea API Market Revenue Share Analysis by Product Type Based on Synthesis Route and Forecasts to 2015 76

7.5.2 South Korea API Market Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2015 79

7.6 South Korea API Market Revenue Share Analysis by Therapeutic Category 82

7.7 South Korea API Market SWOT Analysis 84

7.7.1 Strengths 84

7.7.2 Weaknesses 84

7.7.3 Opportunities 85

7.7.4 Threats 85

8 Appendix 86

8.1 Abbreviations 86

8.2 Market Definitions 86

8.3 Methodology 86

8.3.1 Coverage 86

8.3.2 Secondary Research 87

8.3.3 Primary Research 87

8.3.4 Expert Panel Validation 87

8.4 Contact Us 87

8.5 Disclaimer 88

1.1 List of Tables

Table 1: API Market, Asia-Pacific, Revenues, $m, 2005-2016 14

Table 2: API Market, Asia-Pacific, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2010 and 2016 16

Table 3: API Market, Asia-Pacific, Revenues by Product Type Based on Synthesis Route, $m, 2005-2016 18

Table 4: API Market, Asia-Pacific, Revenue Share Analysis by Product Type Based on Customer Base, %, 2010 and 2016 19

Table 5: API Market, Asia-Pacific, Revenues by Product Type Based on Customer Base, $m, 2005-2016 21

Table 6: API Market, Asia-Pacific, Revenue Share Analysis by Country, 2010 and 2016 22

Table 7: API Market, Japan, Revenues, $m, 2005-2016 30

Table 8: API Market, Japan, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2010 and 2016 31

Table 9: API Market, Japan, Revenues by Product Type Based on Synthesis Route, $m, 2005-2016 33

Table 10: API Market, Japan, Revenue Share Analysis by Product Type Based on Customer Base, %, 2010 and 2016 34

Table 11: API Market, Japan, Revenues by Product Type Based on Customer Base, $m, 2005-2016 36

Table 12: API Market, Japan, Revenue Share Analysis by Therapeutic Category, %, 2010 38

Table 13: API Market, China, Revenues, $m, 2005-2016 45

Table 14: API Market, China, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2010 and 2016 46

Table 15: API Market, China, Revenues by Product Type Based on Synthesis Route, $m, 2005-2016 48

Table 16: API Market, China, Revenue Share Analysis by Product Type Based on Customer Base, %, 2010 and 2016 49

Table 17: API Market, China, Revenues by Product Type Based on Customer Base, $m, 2005-2016 51

Table 18: API Market, China, Revenue Share Analysis by Therapeutic Category, %, 2010 53

Table 19: API Market, China, Export Revenue Share Analysis by Destination, 2010 55

Table 20: API Market, China, Export Revenue Share Analysis by Product Type, %, 2010 56

Table 21: API Market, China, Import Share Analysis by Country, 2010 57

Table 22: API Market, India, Revenues, $m, 2005-2016 62

Table 23: API Market, India, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2010 and 2016 63

Table 24: API Market, India, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2005-2016 65

Table 25: API Market, India, Revenue Share Analysis by Product Type Based on Customer Base, %, 2010 and 2016 66

Table 26: API Market, India, Revenue by Product Type Based on Customer Base, $m, 2005-2016 68

Table 27: API Market, India, Revenue Share Analysis by Therapeutic Categories, 2010 70

Table 28: API Market, South Korea, Revenues, $m, 2005-2015 75

Table 29: API Market, South Korea, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2010 and 2016 76

Table 30: API Market, South Korea, Revenue by Product Type Based on Synthesis Route, $m, 2005-2016 78

Table 31: API Market, South Korea, Revenue Share Analysis by Product Type Based on Customer Base, %, 2010 and 2016 79

Table 32: API Market, South Korea, Revenue by Product Type Based on Customer Base, $m, 2005-2016 81

Table 33: API Market, South Korea, Revenue Share Analysis by Therapeutic Category, 2010 83

1.2 List of Figures

Figure 1: API, Global, Industry Value Chain, 2010 9

Figure 2: API, Asia-Pacific, Distribution Structure 10

Figure 3: API Market, Asia-Pacific, Revenues, $m, 2005-2016 13

Figure 4: API Market, Asia-Pacific, Product Type, 2010 15

Figure 5: API Market, Asia-Pacific, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2010 and 2016 16

Figure 6: API Market, Asia-Pacific, Revenues by Product Type Based on Synthesis Route, $m, 2005-2016 17

Figure 7: API Market, Asia-Pacific, Revenue Share Analysis by Product Type Based on Customer Base, %, 2010 and 2016 19

Figure 8: API Market, Asia-Pacific, Revenues by Product Type Based on Customer Base, $m, 2005-2016 20

Figure 9: API Market, Asia-Pacific, Revenue Share Analysis by Country, %, 2010 and 2016 22

Figure 10: API Market, Asia-Pacific, Force Field Analysis, 2010 24

Figure 11: API Market, Japan, Revenues, $m, 2005-2016 29

Figure 12: API Market, Japan, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2010 and 2016 31

Figure 13: API Market, Japan, Revenues by Product Type Based on Synthesis Route, $m, 2005-2016 32

Figure 14: API Market, Japan, Revenue Share Analysis by Product Type Based on Customer Base, %, 2010 and 2016 34

Figure 15: API Market, Japan, Revenues by Product Type Based on Customer Base, $m, 2005- 2016 35

Figure 16: API Market, Japan, Revenue Share Analysis by Therapeutic Category, %, 2010 37

Figure 17: API Market, Japan, SWOT Analysis, 2010 39

Figure 18: API Market, China, Revenues, $m, 2005-2016 44

Figure 19: API Market, China, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2010 and 2016 46

Figure 20: API Market, China, Revenues by Product Type Based on Synthesis Route, $m, 2005-2016 47

Figure 21: API Market, China, Revenue Share Analysis by Product Type Based on Customer Base, %, 2010 and 2016 49

Figure 22: API Market, China, Revenues by Product Type Based on Customer Base, $m, 2005-2016 50

Figure 23: API Market, China, Revenue Share Analysis by Therapeutic Category, %, 2010 52

Figure 24: API Market, China, Export Revenue Share Analysis by Destination, %, 2010 54

Figure 25: API Market, China, Export Revenue Share Analysis by Product Type, %, 2010 56

Figure 26: API Market, China, Import Share Analysis by Country, %, 2010 57

Figure 27: API Market, China, SWOT Analysis, 2010 58

Figure 28: API Market, India, Revenues, $m, 2005-2016 61

Figure 29: API Market, India, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2010 and 2016 63

Figure 30: API Market, India, Revenue by Product Type Based on Synthesis Route, $m, 2005-2016 64

Figure 31: API Market, India, Revenue Share Analysis by Product Type Based on Customer Base, %, 2010 and 2016 66

Figure 32: API Market, India, Revenue by Product Type Based on Customer Base, $m, 2005-2016 67

Figure 33: API Market, India, Revenue Share Analysis by Therapeutic Categories, %, 2010 69

Figure 34: API Market, India, SWOT Analysis, 2010 71

Figure 35: API Market, South Korea, Revenues, $m, 2005-2015 74

Figure 36: API Market, South Korea, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2010 and 2016 76

Figure 37: API Market, South Korea, Revenue by Product Type Based on Synthesis Route, $m, 2005-2016 77

Figure 38: API Market, South Korea, Revenue Share Analysis by Product Type Based on Customer Base, %, 2010 and 2016 79

Figure 39: API Market, South Korea, Revenue by Product Type Based on Customer Base, $m, 2005-2016 80

Figure 40: API Market, South Korea, Revenue Share Analysis by Therapeutic Category, %, 2010 82

Figure 41: API Market, South Korea, SWOT Analysis, 2010 84

To order this report:

Generic Drug Industry: Active Pharmaceutical Ingredients (API) Market in Asia-Pacific to 2016 - The Merchant Market for Generics Continues to Grow as the Competition Increases

Generic Drug Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker